Azitra stated that its data showed positive outcomes as the company advances towards a first-in-human clinical trial of the ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

Investing.com -- Azitra Inc (NYSE:AZTR) stock surged 42.3% in premarket trading Monday following the announcement of positive preclinical data for its ATR-01 program targeting ichthyosis vulgaris, a ...

Ichthyosis is a condition that causes your skin to become dry, thick, itchy, red, or cracked. Its name comes from the Greek ...

Congenital ichthyosis disorders constitute a complex, genetically heterogeneous group of hereditary skin conditions marked by aberrant epidermal differentiation and impaired barrier function. These ...